|
|
Volumn 11, Issue 13, 2005, Pages 4637-4638
|
|
Radioimmunotherapy for colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOEMBRYONIC ANTIBODY;
HEMOPOIETIC GROWTH FACTOR;
HUMANIZED MONOCLONAL ANTIBODY A33 I 131;
HUMANIZED MONOCLONAL ANTIBODY MN 14 I 131;
IBRITUMOMAB TIUXETAN;
IODINE 131;
MONOCLONAL ANTIBODY;
RADIOISOTOPE;
TOSITUMOMAB I 131;
UNCLASSIFIED DRUG;
ANTIGEN BINDING;
BLOOD TOXICITY;
BONE MARROW TOXICITY;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG EFFICACY;
DRUG TUMOR LEVEL;
EDITORIAL;
HEMATOLOGIC MALIGNANCY;
HUMAN;
ISOTOPE LABELING;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION DOSE FRACTIONATION;
RADIOIMMUNOTHERAPY;
RADIOSENSITIVITY;
SOLID TUMOR;
TUMOR VOLUME;
COLORECTAL NEOPLASMS;
HUMANS;
RADIOIMMUNOTHERAPY;
|
|
EID: 27644483022
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: 10.1158/1078-0432.CCR-05-0485 Document Type: Editorial |
|
Times cited : (12)
|
|
References (7)
|
